Pharmaceutical News and Articles

Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants

RAHWAY, N.J., Oct. 17, 2024 Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced the presentation of positive results from th

Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48

Gilead Sciences, Inc. (Nasdaq GILD) and Merck (NYSE MRK), known as MSD outside of the United States and Canada, today announced new results from a Phase 2 clini

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease

FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer

Preventing, Treating Sports Injuries in Kids: A Guide

all the same qualities that helped them become good athletes. More informationThe American Academy of Pediatrics has more tips to prevent sports injuries in chi

Phase 2 study demonstrates the first successful clinical application of antifibrotic therapy for breast cancer

SAN DIEGO, Oct. 18, 2024. MeCo Diagnostics, a venture-backed startup dedicated to unlocking a new therapeutic modality for cancer, has announced a publication i

Want to Slowly Cut Down on Dietary Salt? Here's How

Did you know that sodium is the bad guy in salt, raising your risks for high blood pressure and other heart ills Luckily for Americans, the U.S. Food and Drug A

Standing More During the Day Does Not Cut Cardiovascular Risk

Standing more does not improve cardiovascular health and may increase the risk for circulatory issues, according to a study published online Oct. 16 in the Inte

Comorbid Diabetes Increases Risk for Lower Extremity Amputation With Kidney Disease

Patients with comorbid diabetes have an elevated risk for lower extremity amputation (LEA) at all stages of chronic kidney disease (CKD) compared with patients